PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples
April 15, 2026
New extraction-to-library prep workflow enables highly accurate long-read sequencing from archived clinical samples, expanding opportunities in cancer research MENLO PARK, Calif. and WOBURN, Mass. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, and Covaris, a PerkinElmer company and leader in sample preparation technologies, today announced a joint workflow has been [...]
Quanterix Debuts Content Innovation Engine at AACR 2026
April 15, 2026
The Content Innovation Engine brings together Akoya's spatial biology platform and Quanterix's immunoassay infrastructure to systematically unlock cancer biology and accelerate the path toward clinical application BILLERICA, Mass. -- Quanterix Corporation (Nasdaq: QTRX) today announced plans to debut its Content Innovation Engine at the American Association for Cancer Research (AACR) Annual Meeting 2026. Built on the integration [...]
Instem Taps ex-Novartis Head of Emerging Technologies to Put Science Behind Practical AI and NAMs
April 15, 2026
Instem, a leading provider of SaaS solutions for preclinical R&D, today announced the appointment of Szczepan Baran, VMD, MS, as Chief Scientific Officer. In the role, Szczepan will lead scientific and AI strategy across in silico predictive modeling, translational safety analytics, and data-driven drug development solutions. BOSTON, USA – Instem, a leading provider of SaaS solutions [...]
ArgusEye AB Appoints Sofia Håkansson Buch as New CEO
April 14, 2026
ArgusEye AB today announce the appointment of Sofia Håkansson Buch as its new Chief Executive Officer (CEO), marking an important step in the company’s next phase of growth. With a strong background in biopharma, Sofia will lead the company’s continued growth and commercialization of its real-time bioprocess monitoring platform. Sofia brings extensive experience from the [...]
April 14, 2026
French pioneer of natural, effective and committed beauty and wellness products will rely on Dassault Systèmes’ science-based technology to accelerate the research and development of ever more effective cosmetic products. Dassault Systèmes will build and deliver virtual twins capable of simulating and predicting how active ingredients interact with skin, to optimize formulations for improved efficacy. [...]
InSphero Launches 3D InSight™ DIGIT Platform for Early Gastrointestinal Toxicity Assessment
April 14, 2026
New Offering Integrates DOPPL’s Patient-Derived Intestinal Organoid Technology with InSphero’s Proven Standardized Screening Model Schlieren, Switzerland – InSphero AG, the global leader in 3D cell-based assays and organ-on-chip systems, today announced the commercial launch of the 3D InSight™ Drug-Induced Gastrointestinal Toxicity (DIGIT) platform, a standardized, high-throughput screening solution for early assessment of gastrointestinal liabilities in drug discovery. [...]
April 14, 2026
Avantes introduces AvaSoftX, a new software foundation built to support the evolving needs of modern spectroscopy workflows. Developed from decades of application expertise and trusted software experience, AvaSoftX represents a major step forward in how users configure measurements, access advanced analysis, and interact with spectral data across laboratory, industrial, and OEM environments. Why a New Software [...]
April 14, 2026
STATESVILLE, N.C. -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced the appointment of Jorge Santos as VP – International Sales – Lab Products Group, further strengthening the Company's commercial leadership as it accelerates growth in key global markets. Santos joins Kewaunee as the newest member of the Company's leadership team and will report directly to [...]
Cepheid and Oxford Nanopore expand partnership following successful phase one collaboration
April 14, 2026
Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease research Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology for real-time genomic analysis, and Cepheid, a Danaher company and a leader in molecular diagnostics for infectious diseases, have announced an expansion of their partnership to [...]
AWS launches Amazon Bio Discovery to accelerate AI-powered research in life sciences
April 14, 2026
A new agentic AI application aims to speed up drug development, helping bring new medical treatments to patients faster. Key takeaways AI-powered application assisting scientists with drug design paired with lab testing creates a loop where each experiment improves the next. Scientists can access leading AI models, view benchmarks, and use an AI agent to [...]

